Skip to content

Influence of latero-lateral versus end-to-end ileo-ascendostomy on recurrence and complications after ileocaecal resection in patients with Crohn's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN45665492
Enrollment
224
Registered
2008-10-09
Start date
2006-02-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease Digestive System Crohn's disease [regional enteritis]

Interventions

Group one: ileocaecal resection with conventional sutured end-to-end ileo-ascendostomy Group two: ileocaecal resection with stapled latero-lateral ileo-ascendostomy The total duration of follow-up fo

Sponsors

Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged greater than or equal to 18 years, either sex 2. Ileal stenosis or stricture due to Crohn's disease with indication for ileocaecal resection or right hemicolectomy 3. First perianastomotic relapse of bowel inflammation with indication for surgical resection

Exclusion criteria

Exclusion criteria: 1. Other intestinal inflammation due to Crohn's disease 2. Aged less than 18 years 3. Pregnancy 4. Given or assumed indication for post-operative medication with azathioprine 5. Impossibility of post-operative dose reduction for cortisone medication

Design outcomes

Primary

MeasureTime frame
Endoscopic proven perianastomotic relapse of bowel inflammation one year after surgical resection (using an endoscopic relapse score).

Secondary

MeasureTime frame
1. Endoscopic proven perianastomotic relapse of bowel inflammation three years after surgical resection (using an endoscopic relapse score): one and three years after randomisation 2. Symptomatic perianastomotic relapse (diarrhoea, pain, fever, weight reduction, increasing inflammation parameters in blood): one and three years after randomisation 3. Relapse with indication for surgical resection: one and three years after randomisation 4. Anastomotic leaks: day of discharge from the hospital

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026